Jefferies Financial Group started coverage on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $65.00 price target on the stock. Separately, Wells Fargo & Company initiated coverage on shares of Aerovate Therapeutics in a research […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report)’s share price fell 8.8% during mid-day trading on Tuesday . The company traded as low as $24.27 and last traded at $24.58. 36,947 shares were traded during mid-day trading, a decline of 63% from the average session volume of 100,754 shares. The stock had previously closed at […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $28.39 and last traded at $27.85, with a volume of 25873 shares trading hands. The stock had previously closed at $25.78. Analysts Set New Price Targets AVTE has been the subject of several […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Hunter Gillies sold 3,489 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $20.23, for a total transaction of $70,582.47. Following the transaction, the insider now directly owns 3,251 shares of the company’s stock, […]